SCHEMBL18322671

SCHEMBL18322671

Cc1cnc(C)c([N+](=O)[O-])c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.42
ALDH1A1 P00352 5/20 0.41
TDP1 Q9NUW8 3/20 0.41
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.37
MEN1 O00255 2/20 0.37
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
APEX1 P27695 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
CASP7 P55210 1/20 0.37
CASP6 P55212 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 4/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29838626 0.85 MAPT (0.44) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL28191633 0.85 MAPT (0.44) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL25394055 0.81 GRIN2D (0.40) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL14868671 0.81 HSP90AA1 (0.41) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL31389931 0.81 ALDH1A1 (0.38) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL3922708 0.77 PKM (0.42) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL5216651 0.76 ALDH1A1 (0.43) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL29892635 0.76 ALDH1A1 (0.43) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL12102640 0.74 ALDH1A1 (0.44) PKMALDH1A1TDP1KMT2AMAPT
SCHEMBL29735712 0.74 ALDH1A1 (0.42) PKMALDH1A1TDP1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105753779-B 2- pyridyl amine compounds and preparation method and application 湖南化工研究院有限公司 2018-06-26 CN claimed
CN-105753779-A 2-pyridylamine compounds, preparing method thereof and applications of the compounds 湖南化工研究院有限公司 2016-07-13 CN claimed
CN-108112251-B NRF2 modulators 葛兰素史克知识产权发展有限公司 2021-03-05 CN disclosed
CN-107820494-B Nuclear receptor modulators 艾伯维公司 2020-10-16 CN disclosed
CN-105753779-B 2- pyridyl amine compounds and preparation method and application 湖南化工研究院有限公司 2018-06-26 CN disclosed
CN-105916857-B Pyrrolopyrrolone derivatives and its purposes as BET inhibitor 诺华股份有限公司 2018-06-22 CN disclosed
CN-105209467-B Imidazopyrrolidinone derivatives and their use in the treatment of disease 诺华股份有限公司 2018-06-08 CN disclosed
CN-108112251-A NRF2 conditioning agents 葛兰素史克知识产权发展有限公司 2018-06-01 CN disclosed
EP-3307739-A1 NRF2 REGULATORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-04-18 EP disclosed
CN-107849024-A With as indoleamine 2, the benzimidazole and imidazopyridine imido of 3 dioxygenase inhibitor activities are for benzamide compound 吉利德科学公司 2018-03-27 CN disclosed
CN-107820494-A Nuclear receptor modulators 艾伯维公司 2018-03-20 CN disclosed
CN-105408335-B Pyrazolo pyrrolidin derivatives and its purposes in disease is treated 诺华股份有限公司 2017-11-17 CN disclosed
WO-2016202253-A1 NRF2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-12-22 WO disclosed
CN-105916857-A Pyrrolopyrrolone derivatives and their use as BET inhibitors 诺华股份有限公司 2016-08-31 CN disclosed
CN-105753779-A 2-pyridylamine compounds, preparing method thereof and applications of the compounds 湖南化工研究院有限公司 2016-07-13 CN disclosed
CN-105209467-A Imidazopyrrolidinone derivatives and their use in the treatment of disease NOVARTIS AG 2015-12-30 CN disclosed